Kyoko Miyamoto
- Immunology top 10%
- Biomarkers in Disease Mechanisms 5
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 6
-
- Tryptophan and brain disorders 2
- Anatomy top 10%
-
- Chronic Lymphocytic Leukemia Research 4
-
- Organ Transplantation Techniques and Outcomes 3
-
- Organ Donation and Transplantation 2
-
- Chronic Myeloid Leukemia Treatments 2
-
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Mina SagaraTatsuhiko KodamaTakao HamakuboYukio ItoAlberto MantovaniAkira SugiyamaH. SatohTakeshi Kurata
- Journals
- Circulation (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kyoko Miyamoto
24 papers receiving 520 citations
Peers
Comparison fields: 5 of 84
- Immunology 317
- Transplantation 23
- Biological Psychiatry 12
- Cancer Research 44
- Anatomy 4
Countries citing papers authored by Kyoko Miyamoto
This map shows the geographic impact of Kyoko Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoko Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoko Miyamoto more than expected).
Fields of papers citing papers by Kyoko Miyamoto
This network shows the impact of papers produced by Kyoko Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoko Miyamoto. The network helps show where Kyoko Miyamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kyoko Miyamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 6 | |
| 9 | 2019 | 7 | |
| 10 | 2018 | 5 | |
| 11 | 2017 | 0 | |
| 12 | 2010 | 2 | |
| 13 | 2009 | 21 | |
| 14 | 2009 | 37 | |
| 15 | 2008 | 83 | |
| 16 | Abstract 1725: Long Pentraxin3 (PTX3) is More Specific than CRP as a Marker for Vascular Inflammation | 2007 | 1 |
| 17 | 2007 | 35 | |
| 18 | 2007 | 30 | |
| 19 | 2007 | 14 | |
| 20 | 2007 | 5 |
About Kyoko Miyamoto
Kyoko Miyamoto is a scholar working on Transplantation, Biological Psychiatry and Genetics, having authored 29 papers that have together received 530 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (6 papers), Biomarkers in Disease Mechanisms (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Organ Transplantation Techniques and Outcomes (3 papers), Organ Donation and Transplantation (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Tryptophan and brain disorders (2 papers). The work is most often cited by research in Immunology (317 citations), Transplantation (23 citations) and Biological Psychiatry (12 citations). Kyoko Miyamoto has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Mina Sagara, Tatsuhiko Kodama, Takao Hamakubo, Yukio Ito, Alberto Mantovani, Akira Sugiyama, H. Satoh, Takeshi Kurata, Hiroshi Ota and Patrick Reid. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.